Parathyroid hormone stimulates bone formation, prevents or reverses bone loss, increases bone mass, bone strength and provides protection against fractures. PTH treatment for postmenopausal, male and glucocorticoid- induced osteoporosis proved to be effective in a number of RCTs
(PTH) increases bone mass and strength and improves bone quality by stimulating new bone formation. ...
Esteban Jódar-GimenoEndocrinology and Metabolism Service, University Hospital “12 de Oc...
Human parathyroid hormone should be used in patients with severe osteoporosis to decrease the rate o...
Osteoporosis is a major public health problem for older women and men. Parathyroid hormone (PTH) (1-...
Bone diseases such as osteoporosis, osteoarthritis, bone tumours and bone fractures are rather commo...
Osteoporotic fractures, especially in elderly people, represent a health concern as they are associa...
Osteoporosis is characterized by the occurrence of a host of fractures. According to densitometric v...
Full length (1-84) parathyroid hormone (PTH) was introduced in Europe as a treatment for postmenopau...
O paratormônio (PTH) estará disponível em breve em nosso mercado como uma possibilidade terapêutica ...
To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...
No Abstract.Journal of Endocrinology, Metabolism and Diabetes of South Africa Vol. 10(2) 2005: 51-5
Corticosteroid-induced osteoporosis is the most common secondary cause of osteoporosis. We conducted...
Treatment of postmenopausal osteoporosis (PMO) is based primarily on antiresorptive agents, includin...
Osteoporosis is the most common generalized bone disease. About 200 million people are affected worl...
BACKGROUND: Once-daily injections of parathyroid hormone or its amino-terminal fragments increase bo...
(PTH) increases bone mass and strength and improves bone quality by stimulating new bone formation. ...
Esteban Jódar-GimenoEndocrinology and Metabolism Service, University Hospital “12 de Oc...
Human parathyroid hormone should be used in patients with severe osteoporosis to decrease the rate o...
Osteoporosis is a major public health problem for older women and men. Parathyroid hormone (PTH) (1-...
Bone diseases such as osteoporosis, osteoarthritis, bone tumours and bone fractures are rather commo...
Osteoporotic fractures, especially in elderly people, represent a health concern as they are associa...
Osteoporosis is characterized by the occurrence of a host of fractures. According to densitometric v...
Full length (1-84) parathyroid hormone (PTH) was introduced in Europe as a treatment for postmenopau...
O paratormônio (PTH) estará disponível em breve em nosso mercado como uma possibilidade terapêutica ...
To investigate the effect of 18 months' parathyroid hormone 1-84 (PTH 1-84) treatment on serum level...
No Abstract.Journal of Endocrinology, Metabolism and Diabetes of South Africa Vol. 10(2) 2005: 51-5
Corticosteroid-induced osteoporosis is the most common secondary cause of osteoporosis. We conducted...
Treatment of postmenopausal osteoporosis (PMO) is based primarily on antiresorptive agents, includin...
Osteoporosis is the most common generalized bone disease. About 200 million people are affected worl...
BACKGROUND: Once-daily injections of parathyroid hormone or its amino-terminal fragments increase bo...
(PTH) increases bone mass and strength and improves bone quality by stimulating new bone formation. ...
Esteban Jódar-GimenoEndocrinology and Metabolism Service, University Hospital “12 de Oc...
Human parathyroid hormone should be used in patients with severe osteoporosis to decrease the rate o...